Translating science into innovative diagnostic solutions

Developing solutions for important global health issues

Quadrant Biosciences works with top academic institutions, medical researchers and engineers to translate breakthrough findings into thoughtfully developed and scientifically sound assessment applications.

Our evolutionary advancements in brain health assessment, autism and Parkinson’s detection, will have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions going forward. Supported through private and state funding, one of these key technologies, ClearEdge, is currently available in the market. In addition, our groundbreaking autism diagnostic aid, Clarifi ASD, is slated for a 2019 release.

Quadrant Biosciences in the News!

The oral microbiome may hold key to the early detection of Parkinson’s disease.

A saliva test to detect oral microbes may offer an accurate way of detecting Parkinson’s in its early stages and further understanding of the disease.

Read article

Quadrant Biosciences Recognized as New York Technology Business of the Year

Quadrant Biosciences Inc. has been awarded the Technology Business of the Year by the New York State Small Business Development Center (SBDC).

Read Story

A Review of MicroRNA Biomarkers in Traumatic Brain Injury

Read about our groundbreaking research and emerging evidence suggesting that microRNAs (miRNAs) may provide information about the injured brain.

Read Story

Quadrant Biosciences is pleased to have been selected as a StartupNY company.

Institute for Human Performance